Session Information

Filter Results:

Show Only CME Accredited Sessions

  • +

    OA14 - Update of Phase 3 Trials and the Role of HPD

    • 11:30 - 13:00
    • 9/10/2019
    • Location: Vienna (2016)
    • IASLC CME Accredited
    • Type: Oral Session
    • Track: Immuno-oncology